| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |